UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension

Molecular and cellular biochemistry, 2021-01, Vol.476 (1), p.333-347

2021

Volltextzugriff (PDF)

Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1137

2024

Volltextzugriff (PDF)

Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases

The Journal of pharmacology and experimental therapeutics, 2009-09, Vol.330 (3), p.670-678

2009

Volltextzugriff (PDF)

Inhibition of Myocardial Remodeling and Heart Failure by Traditional Herbal Medications: Evidence from Ginseng and ginkgo biloba

Reviews in cardiovascular medicine, 2023-07, Vol.24 (7), p.212

2023

Volltextzugriff (PDF)

Ginseng for the treatment of diabetes and diabetes-related cardiovascular complications: a discussion of the evidence

Canadian journal of physiology and pharmacology, 2019-04, Vol.97 (4), p.265-276

2019

Volltextzugriff (PDF)

Cardioprotection by ginseng: experimental and clinical evidence and underlying mechanisms

Canadian journal of physiology and pharmacology, 2018-09, Vol.96 (9), p.859-868

2018

Volltextzugriff (PDF)

Mitochondrial Permeability Transition Pore Opening as an Endpoint to Initiate Cell Death and as a Putative Target for Cardioprotection

Cellular physiology and biochemistry, 2007-01, Vol.20 (1-4), p.1-22

2007

Volltextzugriff (PDF)

Leptin-induced cardiomyocyte hypertrophy is associated with enhanced mitochondrial fission

Molecular and cellular biochemistry, 2019-04, Vol.454 (1-2), p.33-44

2019

Volltextzugriff (PDF)

Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders

Drugs (New York, N.Y.), 2011-10, Vol.71 (15), p.1989-2008

2011

Volltextzugriff (PDF)

Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat

Circulation. Heart failure, 2014-05, Vol.7 (3), p.491-499

2014

Volltextzugriff (PDF)

NHE-1: Still a viable therapeutic target

Journal of molecular and cellular cardiology, 2013-08, Vol.61, p.77-82

Karmazyn, Morris

2013

Volltextzugriff (PDF)

Inhibition of angiotensin II–induced hypertrophy and cardiac dysfunction by North American ginseng ( Panax quinquefolius )

Canadian journal of physiology and pharmacology, 2021-05, Vol.99 (5), p.512-521

2021

Volltextzugriff (PDF)

Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation

PloS one, 2016-03, Vol.11 (3), p.e0149125-e0149125

2016

Volltextzugriff (PDF)

Characterization of In Vitro Engineered Human Adipose Tissues: Relevant Adipokine Secretion and Impact of TNF-α

PloS one, 2015-09, Vol.10 (9), p.e0137612-e0137612

2015

Volltextzugriff (PDF)

miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy

PloS one, 2016-03, Vol.11 (3), p.e0151515-e0151515

2016

Volltextzugriff (PDF)

The Remaining Conundrum of the Role of the Na + /H + Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?

Reviews in cardiovascular medicine, 2022-08, Vol.23 (8), p.284

2022

Volltextzugriff (PDF)

Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation

PloS one, 2016-02, Vol.11 (2), p.e0148482-e0148482

2016

Volltextzugriff (PDF)

Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failure

Current pharmaceutical design, 2014-02, Vol.20 (4), p.646-651

2014

Volltextzugriff (PDF)

Whey Protein Lycosome Formulation Improves Vascular Functions and Plasma Lipids with Reduction of Markers of Inflammation and Oxidative Stress in Prehypertension

TheScientificWorld, 2012-01, Vol.2012 (2012), p.1-7

2012

Volltextzugriff (PDF)

Activation of Both the Calpain and Ubiquitin-Proteasome Systems Contributes to Septic Cardiomyopathy through Dystrophin Loss/Disruption and mTOR Inhibition

PloS one, 2016-11, Vol.11 (11), p.e0166839-e0166839

2016

Volltextzugriff (PDF)

Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes

PloS one, 2016-09, Vol.11 (9), p.e0163250-e0163250

2016

Volltextzugriff (PDF)

The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes

Circulation research, 2003-08, Vol.93 (4), p.277-279

2003

Volltextzugriff (PDF)

Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy

PloS one, 2015-04, Vol.10 (4), p.e0123318-e0123318

2015

Volltextzugriff (PDF)

Identification of fat mass and obesity associated (FTO) protein expression in cardiomyocytes: regulation by leptin and its contribution to leptin-induced hypertrophy

PloS one, 2013-09, Vol.8 (9), p.e74235-e74235

2013

Volltextzugriff (PDF)

Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review

Molecular and cellular biochemistry, 2023-11, Vol.478 (11), p.2539-2551

2023

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(212)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(177)
Science & Technology
(147)
Life Sciences & Biomedicine
(136)
Rats
(111)
Male
(81)
Rats, Sprague-Dawley
(77)
Cardiovascular System & Cardiology
(66)
Cardiac & Cardiovascular Systems
(65)
Humans
(64)
Biological And Medical Sciences
(62)
Heart
(51)
Medical Sciences
(47)
Sodium-Hydrogen Exchangers - Antagonists & Inhibitors
(41)
Pharmacology & Pharmacy
(40)
Myocardium - Metabolism
(39)
Cells, Cultured
(37)
Physiology
(37)
Hypertrophy
(34)
In Vitro Techniques
(33)
Myocytes, Cardiac - Metabolism
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension

Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin

Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases

Inhibition of Myocardial Remodeling and Heart Failure by Traditional Herbal Medications: Evidence from Ginseng and ginkgo biloba

Ginseng for the treatment of diabetes and diabetes-related cardiovascular complications: a discussion of the evidence

Cardioprotection by ginseng: experimental and clinical evidence and underlying mechanisms

Mitochondrial Permeability Transition Pore Opening as an Endpoint to Initiate Cell Death and as a Putative Target for Cardioprotection

Leptin-induced cardiomyocyte hypertrophy is associated with enhanced mitochondrial fission

Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders

Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat

NHE-1: Still a viable therapeutic target

Inhibition of angiotensin II–induced hypertrophy and cardiac dysfunction by North American ginseng ( Panax quinquefolius )

Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation

Characterization of In Vitro Engineered Human Adipose Tissues: Relevant Adipokine Secretion and Impact of TNF-α

miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy

The Remaining Conundrum of the Role of the Na + /H + Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?

Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation

Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failure

Whey Protein Lycosome Formulation Improves Vascular Functions and Plasma Lipids with Reduction of Markers of Inflammation and Oxidative Stress in Prehypertension

Activation of Both the Calpain and Ubiquitin-Proteasome Systems Contributes to Septic Cardiomyopathy through Dystrophin Loss/Disruption and mTOR Inhibition

Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes

The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes

Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy

Identification of fat mass and obesity associated (FTO) protein expression in cardiomyocytes: regulation by leptin and its contribution to leptin-induced hypertrophy

Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review

Suchergebnisse filtern